DMPK and myotonic dystrophy type 1: Perturbation of alternative splicing through sequestration of muscleblind-like (MBNL) family of factors by mutant DMPK RNA and upregulation of CUG/Elav-like (CELF) proteins [24,25] are the best described pathogenic mechanisms in DM1.